
FDA-cleared OptiLight IPL treatment for dry eye disease and meibomian gland dysfunction performed by a board-certified ophthalmologist in Roslyn Heights, Nassau County, and the North Shore of Long Island.
OptiLight is an advanced form of intense pulsed light (IPL) therapy specifically FDA-cleared for the treatment of dry eye disease associated with meibomian gland dysfunction (MGD). MGD is a leading cause of chronic dry eye and occurs when the oil-producing glands along the eyelids do not function properly, leading to tear film instability and inflammation.
At Politi Eyecare & Aesthetics, OptiLight treatment is provided as part of a comprehensive, physician-directed dry eye evaluation. Advanced diagnostic testing is used to assess tear quality, eyelid gland function, and ocular surface health to determine whether OptiLight therapy is appropriate.
OptiLight IPL works by delivering precise pulses of light to the skin around the eyes, reducing inflammation, improving meibomian gland function, and helping restore a healthier tear film. Treatment is designed to improve long-term comfort and reduce dry eye symptoms rather than simply masking them.
OptiLight IPL may be recommended for patients with:
Treatment candidacy is determined through a comprehensive eye examination.
OptiLight treatments are performed in-office and typically require minimal downtime. A series of treatment sessions is often recommended to achieve optimal results. Patients may experience gradual improvement in eye comfort, tear stability, and visual quality over time.
Treatment plans are individualized based on severity of disease, response to therapy, and overall ocular health.
OptiLight IPL is most effective when incorporated into a comprehensive dry eye management plan. Physician-directed care ensures accurate diagnosis, appropriate patient selection, and integration with other medical or procedural treatments when indicated.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.